TreeWAS – Variant ID: rs7253363

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N39.3 Stress incontinence	0.021	0.979	0.000
D22.5 Melanocytic naevi of trunk	0.020	0.980	0.000
E10.9 Without complications	0.000	0.983	0.017
E10 Insulin-dependent diabetes mellitus	0.000	0.983	0.017
E11 Non-insulin-dependent diabetes mellitus	0.000	0.983	0.017
E10-E14 Diabetes mellitus	0.000	0.984	0.016
E11.2 With renal complications	0.000	0.985	0.015
E11.0 With coma	0.000	0.985	0.015
E11.1 With ketoacidosis	0.000	0.985	0.015
E11.4 With neurological complications	0.000	0.985	0.014
E13 Other specified diabetes mellitus	0.000	0.986	0.014
E11.5 With peripheral circulatory complications	0.000	0.986	0.013
E10.4 With neurological complications	0.000	0.987	0.013
E10.5 With peripheral circulatory complications	0.000	0.987	0.013
E10.3 With ophthalmic complications	0.000	0.987	0.013
E11.8 With unspecified complications	0.000	0.987	0.013
E10.0 With coma	0.000	0.987	0.013
E10.8 With unspecified complications	0.000	0.987	0.013
E10.6 With other specified complications	0.000	0.987	0.013
E11.7 With multiple complications	0.000	0.987	0.012
E10.7 With multiple complications	0.000	0.988	0.012
E11.6 With other specified complications	0.000	0.988	0.012
E13.9 Without complications	0.000	0.988	0.012
E14 Unspecified diabetes mellitus	0.000	0.988	0.012
E12 Malnutrition-related diabetes mellitus	0.000	0.988	0.012
E11.3 With ophthalmic complications	0.000	0.989	0.011
E10.1 With ketoacidosis	0.000	0.989	0.011
E10.2 With renal complications	0.000	0.989	0.011
E13.3 With ophthalmic complications	0.000	0.989	0.010
E14.6 With other specified complications	0.000	0.990	0.010
E13.8 With unspecified complications	0.000	0.990	0.010
E13.7 With multiple complications	0.000	0.990	0.010
E13.6 With other specified complications	0.000	0.990	0.010
E13.5 With peripheral circulatory complications	0.000	0.990	0.010
E13.4 With neurological complications	0.000	0.990	0.010
E13.2 With renal complications	0.000	0.990	0.010
E13.1 With ketoacidosis	0.000	0.990	0.010
E13.0 With coma	0.000	0.990	0.010
E04.2 Non-toxic multinodular goitre	0.010	0.990	0.000
E14.3 With ophthalmic complications	0.000	0.991	0.009
E14.1 With ketoacidosis	0.000	0.991	0.009
E14.4 With neurological complications	0.000	0.991	0.009
E14.5 With peripheral circulatory complications	0.000	0.991	0.009
E14.0 With coma	0.000	0.991	0.009
E14.7 With multiple complications	0.000	0.991	0.009
E14.8 With unspecified complications	0.000	0.991	0.009
E12.9 Without complications	0.000	0.991	0.008
E12.8 With unspecified complications	0.000	0.991	0.008
E12.7 With multiple complications	0.000	0.991	0.008
E12.6 With other specified complications	0.000	0.991	0.008
E12.5 With peripheral circulatory complications	0.000	0.991	0.008
E12.4 With neurological complications	0.000	0.991	0.008
E12.3 With ophthalmic complications	0.000	0.991	0.008
E12.2 With renal complications	0.000	0.991	0.008
E12.1 With ketoacidosis	0.000	0.991	0.008
E12.0 With coma	0.000	0.991	0.008
E14.2 Withrenal complications	0.000	0.992	0.008
K51.9 Ulcerative colitis, unspecified	0.000	0.992	0.008
E04 Other non-toxic goitre	0.007	0.993	0.000
E11.9 Without complications	0.000	0.993	0.007
K51 Ulcerative colitis	0.000	0.993	0.007
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.994	0.006
D22.6 Melanocytic naevi of upper limb, including shoulder	0.006	0.994	0.000
D22 Melanocytic naevi	0.006	0.994	0.000
E04.9 Non-toxic goitre, unspecified	0.006	0.994	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.994	0.006
E04.1 Non-toxic single thyroid nodule	0.006	0.994	0.000
Y52 Agents primarily affecting the cardiovascular system	0.000	0.994	0.006
K51.5 Mucosal proctocolitis	0.000	0.994	0.006
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.995	0.005
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.995	0.005
E04.8 Other specified non-toxic goitre	0.005	0.995	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.995	0.005
Y52.4 Angiotensin-converting-enzyme inhibitors	0.000	0.995	0.005
K51.4 Pseudopolyposis of colon	0.000	0.995	0.005
Y42.5 Other oestrogens and progestogens	0.000	0.995	0.005
Y42.0 Glucocorticoids and synthetic analogs	0.000	0.995	0.005
K51.1 Ulcerative (chronic) ileocolitis	0.000	0.995	0.005
D22.4 Melanocytic naevi of scalp and neck	0.005	0.995	0.000
E04.0 Non-toxic diffuse goitre	0.005	0.995	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.000	0.995	0.005
K51.8 Other ulcerative colitis	0.000	0.995	0.005
Y42.7 Androgens and anabolic congeners	0.000	0.995	0.005
K51.2 Ulcerative (chronic) proctitis	0.000	0.995	0.005
D22.2 Melanocytic naevi of ear and external auricular canal	0.005	0.995	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.995	0.005
Y42.1 Thyroid hormones and substitutes	0.000	0.995	0.005
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.000	0.995	0.005
D22.0 Melanocytic naevi of lip	0.005	0.995	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.000	0.995	0.005
Y52.1 Calcium-channel blockers	0.000	0.995	0.005
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.995	0.004
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.996	0.004
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.000	0.996	0.004
Y42.4 Oral contraceptives	0.000	0.996	0.004
Y41 Other systemic anti-infectives and antiparasitics	0.000	0.996	0.004
Y42.9 Other and unspecified hormone antagonists	0.000	0.996	0.004
Y52.8 Antivaricose drugs, including sclerosing agents	0.000	0.996	0.004
Y42.2 Antithyroid drugs	0.000	0.996	0.004
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.996	0.004
D22.9 Melanocytic naevi, unspecified	0.004	0.996	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.996	0.004
Y52.7 Peripheral vasodilators	0.000	0.996	0.004
Y47 Sedatives, hypnotics and antianxiety drugs	0.000	0.996	0.004
Y46 Antiepileptics and anti-Parkinsonism drugs	0.000	0.996	0.004
O70.0 First degree perineal laceration during delivery	0.004	0.996	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.996	0.004
Y54.5 Other diuretics	0.000	0.996	0.004
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.000	0.996	0.004
Y49 Psychotropic drugs, not elsewhere classified	0.000	0.996	0.004
Y41.5 Antiviral drugs	0.000	0.996	0.004
E14.9 Without complications	0.000	0.996	0.004
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.000	0.996	0.004
Y59 Other and unspecified vaccines and biological substances	0.000	0.996	0.004
Y51 Drugs primarily affecting the autonomic nervous system	0.000	0.996	0.004
Y44 Agents primarily affecting blood constituents	0.000	0.996	0.004
D22.1 Melanocytic naevi of eyelid, including canthus	0.003	0.996	0.000
Y54.4 Loop [high-ceiling] diuretics	0.000	0.996	0.003
Y54.0 Mineralocorticoids	0.000	0.996	0.003
Y58 Bacterial vaccines	0.000	0.996	0.003
Y41.0 Sulphonamides	0.000	0.996	0.003
Y50 Central nervous system stimulants, not elsewhere classified	0.000	0.996	0.003
K82.8 Other specified diseases of gallbladder	0.000	0.996	0.004
Y48 Anaesthetics and therapeutic gases	0.000	0.996	0.003
Y54.8 Agents affecting uric acid metabolism	0.000	0.997	0.003
Y54.7 Agents affecting calcification	0.000	0.997	0.003
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.003
Z37.0 Single live birth	0.003	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
Y54.9 Mineral salts, not elsewhere classified	0.000	0.997	0.003
Y54.6 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
Y54.2 Carbonic-anhydrase inhibitors	0.000	0.997	0.003
E05.9 Thyrotoxicosis, unspecified	0.003	0.997	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
Y41.4 Anthelminthics	0.000	0.997	0.003
Y41.3 Other antiprotozoal drugs	0.000	0.997	0.003
Y46.7 Anti-Parkinsonism drugs	0.000	0.997	0.003
Y47.1 Benzodiazepines	0.000	0.997	0.003
Y41.1 Antimycobacterial drugs	0.000	0.997	0.003
Y53 Agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
S52.50 Fracture of lower end of radius (closed)	0.000	0.997	0.003
Y46.6 Other and unspecified antiepileptics	0.000	0.997	0.003
Y49.5 Other antipsychotics and neuroleptics	0.000	0.997	0.003
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.003
Y54.3 Benzothiadiazine derivatives	0.000	0.997	0.003
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.000	0.997	0.003
Y49.2 Other and unspecified antidepressants	0.000	0.997	0.003
Y48.3 Local anaesthetics	0.000	0.997	0.003
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.997	0.003
D22.7 Melanocytic naevi of lower limb, including hip	0.003	0.997	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.000	0.997	0.003
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.000	0.997	0.003
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.000	0.997	0.003
Y47.4 Bromine compounds	0.000	0.997	0.003
Y47.3 Paraldehyde	0.000	0.997	0.003
Y47.2 Chloral derivatives	0.000	0.997	0.003
Y47.0 Barbiturates, not elsewhere classified	0.000	0.997	0.003
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.000	0.997	0.003
Y46.8 Antispasticity drugs	0.000	0.997	0.003
Y46.3 Deoxybarbiturates	0.000	0.997	0.003
Y46.2 Hydantoin derivatives	0.000	0.997	0.003
Y46.1 Oxazolidinediones	0.000	0.997	0.003
Y46.0 Succinimides	0.000	0.997	0.003
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.003
Y59.3 Immunoglobulin	0.000	0.997	0.003
Y40 Systemic antibiotics	0.000	0.997	0.003
H35.8 Other specified retinal disorders	0.000	0.997	0.003
E00-E07 Disorders of thyroid gland	0.002	0.997	0.001
Y49.9 Psychotropic drug, unspecified	0.000	0.997	0.003
Y49.7 Psychostimulants with abuse potential	0.000	0.997	0.003
Y49.6 Psychodysleptics [hallucinogens]	0.000	0.997	0.003
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.003
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
E05 Thyrotoxicosis [hyperthyroidism]	0.003	0.997	0.000
Y44.5 Thrombolytic drugs	0.000	0.997	0.003
Y46.5 Valproic acid	0.000	0.997	0.003
Y56.9 Topical agent, unspecified	0.000	0.997	0.003
Y56.8 Other topical agents	0.000	0.997	0.003
Y56.7 Dental drugs, topically applied	0.000	0.997	0.003
Y56.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.003
Y56.5 Ophthalmological drugs and preparations	0.000	0.997	0.003
Y56.2 Local astringents and local detergents	0.000	0.997	0.003
Y56.1 Antipruritics	0.000	0.997	0.003
N48.6 Balanitis xerotica obliterans	0.000	0.997	0.003
Y44.6 Natural blood and blood products	0.000	0.997	0.003
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
Y51.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
Y51.0 Anticholinesterase agents	0.000	0.997	0.003
Y59.9 Vaccine or biological substance, unspecified	0.000	0.997	0.003
Y59.8 Other specified vaccines and biological substances	0.000	0.997	0.003
Y59.2 Protozoal vaccines	0.000	0.997	0.003
Y59.1 Rickettsial vaccines	0.000	0.997	0.003
Y49.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.003
Y44.9 Other and unspecified agents affecting blood constituents	0.000	0.997	0.003
Y44.7 Plasma substitutes	0.000	0.997	0.003
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.000	0.997	0.003
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.003
Y58.9 Other and unspecified bacterial vaccines	0.000	0.997	0.003
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.000	0.997	0.003
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.000	0.997	0.003
Y58.5 Diphtheria vaccine	0.000	0.997	0.003
Y58.4 Tetanus vaccine	0.000	0.997	0.003
Y58.3 Plague vaccine	0.000	0.997	0.003
Y58.2 Cholera vaccine	0.000	0.997	0.003
Y58.1 Typhoid and paratyphoid vaccine	0.000	0.997	0.003
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.003
Y50.9 Central nervous system stimulant, unspecified	0.000	0.997	0.003
Y50.8 Other central nervous system stimulants	0.000	0.997	0.003
Y50.1 Opioid receptor antagonists	0.000	0.997	0.003
Y50.0 Analeptics	0.000	0.997	0.003
Y57 Other and unspecified drugs and medicaments	0.000	0.997	0.003
Y56.3 Emollients, demulcents and protectants	0.000	0.997	0.003
Y58.0 BCG vaccine	0.000	0.997	0.003
Y59.0 Viral vaccines	0.000	0.997	0.003
D22.3 Melanocytic naevi of other and unspecified parts of face	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.000	0.997	0.003
Y48.1 Parenteral anaesthetics	0.000	0.997	0.003
Y48.0 Inhaled anaesthetics	0.000	0.997	0.003
Y55.0 Oxytocic drugs	0.000	0.997	0.003
Y46.4 Iminostilbenes	0.000	0.997	0.003
Y49.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.003
Y50.2 Methylxanthines, not elsewhere classified	0.000	0.997	0.003
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.000	0.997	0.003
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.997	0.003
Y55.5 Anticommon cold drugs	0.000	0.997	0.003
Y55.4 Expectorants	0.000	0.997	0.003
Y55.3 Antitussives	0.000	0.997	0.003
Y55.2 Other and unspecified agents primarily acting on muscles	0.000	0.997	0.003
Y44.2 Anticoagulants	0.000	0.997	0.003
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.997	0.002
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.997	0.002
Y45.1 Salicylates	0.000	0.997	0.003
Y55.6 Antiasthmatics, not elsewhere classified	0.000	0.997	0.002
Z37 Outcome of delivery	0.003	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.000	0.997	0.002
Y53.3 Saline and osmotic laxatives	0.000	0.997	0.002
Y45.8 Other analgesics and antipyretics	0.000	0.997	0.002
Z37.2 Twins, both liveborn	0.003	0.997	0.000
Y45.5 4-Aminophenol derivatives	0.000	0.997	0.002
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.002
Y53.7 Emetics	0.000	0.997	0.002
Y53.5 Digestants	0.000	0.997	0.002
Y53.0 Histamine H2-receptor antagonists	0.000	0.997	0.002
Y40.7 Antifungal antibiotics, systemically used	0.000	0.997	0.002
Y45.4 Antirheumatics	0.000	0.997	0.002
N39 Other disorders of urinary system	0.003	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.002
E28.2 Polycystic ovarian syndrome	0.000	0.997	0.002
Y53.6 Antidiarrhoeal drugs	0.000	0.997	0.002
Y40.5 Aminoglycosides	0.000	0.997	0.002
Y48.4 Anaesthetic, unspecified	0.000	0.997	0.002
Y53.2 Stimulant laxatives	0.000	0.997	0.002
Y40.3 Macrolides	0.000	0.997	0.002
E05.0 Thyrotoxicosis with diffuse goitre	0.002	0.997	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.000	0.997	0.002
Y53.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.002
N39.4 Other specified urinary incontinence	0.002	0.998	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.002	0.998	0.001
Y45.2 Propionic acid derivatives	0.000	0.998	0.002
Y40.2 Chloramphenicol group	0.000	0.998	0.002
Y53.4 Other laxatives	0.000	0.998	0.002
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.002	0.998	0.001
E00 Congenital iodine-deficiency syndrome	0.002	0.998	0.001
Y40.4 Tetracyclines	0.000	0.998	0.002
E05.5 Thyroid crisis or storm	0.002	0.998	0.000
E05.4 Thyrotoxicosis factitia	0.002	0.998	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.002	0.998	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.000	0.998	0.002
Y57.8 Other drugs and medicaments	0.000	0.998	0.002
Z37.1 Single stillbirth	0.002	0.998	0.000
V18.2 Unspecified pedal cyclist injured in nontraffic accident	0.000	0.998	0.002
Y40.6 Rifamycins	0.000	0.998	0.002
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
Y57.7 Vitamins, not elsewhere classified	0.000	0.998	0.002
Y57.4 Pharmaceutical excipients	0.000	0.998	0.002
Y57.3 Alcohol deterrents	0.000	0.998	0.002
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
Y57.1 Lipotropic drugs	0.000	0.998	0.002
Y57.0 Appetite depressants [anorectics]	0.000	0.998	0.002
N48.8 Other specified disorders of penis	0.000	0.998	0.002
E28 Ovarian dysfunction	0.000	0.998	0.002
Y43 Primarily systemic agents	0.000	0.998	0.002
E05.8 Other thyrotoxicosis	0.002	0.998	0.000
Y40.0 Penicillins	0.000	0.998	0.002
Z37.3 Twins, one liveborn and one stillborn	0.002	0.998	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.002	0.998	0.000
T17.2 Foreign body in pharynx	0.002	0.998	0.000
Z37.5 Other multiple births, all liveborn	0.002	0.998	0.000
E20.9 Hypoparathyroidism, unspecified	0.000	0.998	0.002
Y57.6 Other diagnostic agents	0.000	0.998	0.002
N48.4 Impotence of organic origin	0.000	0.998	0.002
Y57.5 X-ray contrast media	0.000	0.998	0.002
E20 Hypoparathyroidism	0.000	0.998	0.002
N48 Other disorders of penis	0.000	0.998	0.002
E06 Thyroiditis	0.001	0.998	0.001
N39.1 Persistent proteinuria, unspecified	0.002	0.998	0.000
Z37.9 Outcome of delivery unspecified	0.002	0.998	0.000
Z37.7 Other multiple births, all stillborn	0.002	0.998	0.000
Z37.6 Other multiple births, some liveborn	0.002	0.998	0.000
Z37.4 Twins, both stillborn	0.002	0.998	0.000
N39.2 Orthostatic proteinuria, unspecified	0.002	0.998	0.000
E20-E35 Disorders of other endocrine glands	0.000	0.998	0.002
Y45.0 Opioids and related analgesics	0.000	0.998	0.002
K14.0 Glossitis	0.000	0.998	0.002
Y40.8 Other systemic antibiotics	0.000	0.998	0.002
E07 Other disorders of thyroid	0.001	0.998	0.001
Y43.4 Immunosuppressive agents	0.000	0.998	0.002
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.001	0.998	0.001
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.001	0.998	0.001
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.001	0.998	0.001
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.001	0.998	0.001
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.001	0.998	0.001
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.001	0.998	0.001
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.001	0.998	0.001
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.001	0.998	0.001
Y40.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
D68.0 Von Willebrand's disease	0.000	0.998	0.002
E24 Cushing's syndrome	0.000	0.998	0.002
N85.2 Hypertrophy of uterus	0.002	0.998	0.000
E20.1 Pseudohypoparathyroidism	0.000	0.998	0.002
E28.9 Ovarian dysfunction, unspecified	0.000	0.998	0.002
E28.8 Other ovarian dysfunction	0.000	0.998	0.002
E28.1 Androgen excess	0.000	0.998	0.002
E28.0 Oestrogen excess	0.000	0.998	0.002
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.002	0.998	0.000
N48.9 Disorder of penis, unspecified	0.000	0.998	0.002
Y43.9 Primarily systemic agent, unspecified	0.000	0.998	0.002
Y43.8 Other primarily systemic agents, not elsewhere classified	0.000	0.998	0.002
Y43.6 Enzymes, not elsewhere classified	0.000	0.998	0.002
Y43.5 Acidifying and alkalising agents	0.000	0.998	0.002
E23 Hypofunction and other disorders of pituitary gland	0.000	0.998	0.002
E28.3 Primary ovarian failure	0.000	0.998	0.002
E27 Other disorders of adrenal gland	0.000	0.998	0.002
E20.8 Other hypoparathyroidism	0.000	0.998	0.002
N48.0 Leukoplakia of penis	0.000	0.998	0.002
T18.1 Foreign body in oesophagus	0.000	0.998	0.002
Y43.2 Antineoplastic natural products	0.000	0.998	0.002
C67.9 Bladder, unspecified	0.000	0.998	0.002
E20.0 Idiopathic hypoparathyroidism	0.000	0.998	0.002
E27.9 Disorder of adrenal gland, unspecified	0.000	0.998	0.002
N48.5 Ulcer of penis	0.000	0.998	0.002
O03.9 Complete or unspecified, without complication	0.002	0.998	0.000
Y57.9 Drug or medicament, unspecified	0.000	0.998	0.001
E32 Diseases of thymus	0.000	0.998	0.002
E31 Polyglandular dysfunction	0.000	0.998	0.002
E06.5 Other chronic thyroiditis	0.001	0.998	0.001
E06.4 Drug-induced thyroiditis	0.001	0.998	0.001
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.001	0.998	0.001
E06.0 Acute thyroiditis	0.001	0.998	0.001
E26 Hyperaldosteronism	0.000	0.998	0.002
N47 Redundant prepuce, phimosis and paraphimosis	0.000	0.998	0.002
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.998	0.002
E06.1 Subacute thyroiditis	0.001	0.998	0.001
E25 Adrenogenital disorders	0.000	0.998	0.002
E06.9 Thyroiditis, unspecified	0.001	0.998	0.001
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.998	0.002
E30 Disorders of puberty, not elsewhere classified	0.000	0.998	0.002
K22.2 Oesophageal obstruction	0.002	0.998	0.000
N48.3 Priapism	0.000	0.998	0.002
Y43.1 Antineoplastic antimetabolites	0.000	0.998	0.002
C19 Malignant neoplasm of rectosigmoid junction	0.000	0.998	0.002
E06.3 Autoimmune thyroiditis	0.001	0.998	0.001
G93.2 Benign intracranial hypertension	0.000	0.998	0.002
M23.24 Derangement of meniscus due to old tear or injury (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.000	0.998	0.002
M79.79 Fibromyalgia (Site unspecified)	0.000	0.998	0.002
E07.1 Dyshormogenetic goitre	0.001	0.998	0.001
E07.0 Hypersecretion of calcitonin	0.001	0.998	0.001
E24.9 Cushing's syndrome, unspecified	0.000	0.998	0.002
M54.57 Low back pain (Lumbosacral region)	0.000	0.998	0.002
N48.2 Other inflammatory disorders of penis	0.000	0.998	0.002
S52.5 Fracture of lower end of radius	0.000	0.998	0.002
E22 Hyperfunction of pituitary gland	0.000	0.998	0.002
E23.2 Diabetes insipidus	0.000	0.998	0.002
E23.0 Hypopituitarism	0.000	0.998	0.002
E24.2 Drug-induced Cushing's syndrome	0.000	0.998	0.002
E24.0 Pituitary-dependent Cushing's disease	0.000	0.998	0.002
E65 Localised adiposity	0.000	0.998	0.002
E07.8 Other specified disorders of thyroid	0.001	0.998	0.001
E23.6 Other disorders of pituitary gland	0.000	0.998	0.002
E27.1 Primary adrenocortical insufficiency	0.000	0.998	0.002
E29 Testicular dysfunction	0.000	0.998	0.002
E24.8 Other Cushing's syndrome	0.000	0.998	0.001
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.000	0.998	0.001
E24.3 Ectopic ACTH syndrome	0.000	0.998	0.001
E24.1 Nelson's syndrome	0.000	0.998	0.001
Y43.0 Antiallergic and antiemetic drugs	0.000	0.998	0.001
E27.2 Addisonian crisis	0.000	0.998	0.001
E32.9 Disease of thymus, unspecified	0.000	0.998	0.001
E23.1 Drug-induced hypopituitarism	0.000	0.998	0.001
E31.0 Autoimmune polyglandular failure	0.000	0.998	0.001
I73.9 Peripheral vascular disease, unspecified	0.002	0.998	0.000
E26.9 Hyperaldosteronism, unspecified	0.000	0.998	0.001
E27.5 Adrenomedullary hyperfunction	0.000	0.998	0.001
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.998	0.001
E27.0 Other adrenocortical overactivity	0.000	0.998	0.001
O36.8 Maternal care for other specified foetal problems	0.002	0.998	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.000	0.998	0.001
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.000	0.998	0.001
E27.8 Other specified disorders of adrenal gland	0.000	0.998	0.001
E34 Other endocrine disorders	0.000	0.998	0.001
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.000	0.998	0.001
E31.9 Polyglandular dysfunction, unspecified	0.000	0.998	0.001
E31.8 Other polyglandular dysfunction	0.000	0.998	0.001
E31.1 Polyglandular hyperfunction	0.000	0.998	0.001
E32.1 Abscess of thymus	0.000	0.998	0.001
E32.0 Persistent hyperplasia of thymus	0.000	0.998	0.001
E25.9 Adrenogenital disorder, unspecified	0.000	0.998	0.001
E25.8 Other adrenogenital disorders	0.000	0.998	0.001
E26.8 Other hyperaldosteronism	0.000	0.998	0.001
E26.1 Secondary hyperaldosteronism	0.000	0.998	0.001
H35.3 Degeneration of macula and posterior pole	0.002	0.998	0.000
N39.9 Disorder of urinary system, unspecified	0.001	0.998	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.998	0.001
M65.34 Trigger finger-Hand	0.000	0.998	0.002
E07.9 Disorder of thyroid, unspecified	0.001	0.998	0.001
E26.0 Primary hyperaldosteronism	0.000	0.998	0.001
E30.9 Disorder of puberty, unspecified	0.000	0.998	0.001
E30.8 Other disorders of puberty	0.000	0.998	0.001
E30.1 Precocious puberty	0.000	0.998	0.001
E30.0 Delayed puberty	0.000	0.998	0.001
E32.8 Other diseases of thymus	0.000	0.998	0.001
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.000	0.998	0.001
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.000	0.998	0.001
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.000	0.998	0.001
H33.3 Retinal breaks without detachment	0.002	0.998	0.000
E23.7 Disorder of pituitary gland, unspecified	0.000	0.998	0.001
N48.1 Balanoposthitis	0.000	0.998	0.001
E22.8 Other hyperfunction of pituitary gland	0.000	0.998	0.001
I72.4 Aneurysm of artery of lower extremity	0.001	0.998	0.000
I72.3 Aneurysm of iliac artery	0.001	0.998	0.000
O36.5 Maternal care for poor foetal growth	0.001	0.998	0.000
E65-E68 Obesity and other hyperalimentation	0.000	0.998	0.001
E22.9 Hyperfunction of pituitary gland, unspecified	0.000	0.998	0.001
E29.8 Other testicular dysfunction	0.000	0.998	0.001
E29.0 Testicular hyperfunction	0.000	0.998	0.001
G43.1 Migraine with aura [classical migraine]	0.001	0.998	0.000
N35.9 Urethral stricture, unspecified	0.002	0.998	0.000
V18 Pedal cyclist injured in noncollision transport accident	0.000	0.998	0.001
D12.4 Descending colon	0.000	0.999	0.001
E22.0 Acromegaly and pituitary gigantism	0.000	0.999	0.001
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.001	0.999	0.000
N64.8 Other specified disorders of breast	0.000	0.999	0.001
D12.3 Transverse colon	0.000	0.999	0.001
E29.9 Testicular dysfunction, unspecified	0.000	0.999	0.001
I65.2 Occlusion and stenosis of carotid artery	0.001	0.999	0.000
T17 Foreign body in respiratory tract	0.001	0.999	0.000
M65.86 Other synovitis and tenosynovitis (Lower leg)	0.000	0.999	0.001
S52.51 Fracture of lower end of radius (open)	0.000	0.999	0.001
D68.2 Hereditary deficiency of other clotting factors	0.000	0.999	0.001
S09.9 Unspecified injury of head	0.000	0.999	0.001
I71 Aortic aneurysm and dissection	0.001	0.999	0.000
M81.90 Osteoporosis, unspecified (Multiple sites)	0.001	0.999	0.000
E34.9 Endocrine disorder, unspecified	0.000	0.999	0.001
E34.5 Androgen resistance syndrome	0.000	0.999	0.001
E34.4 Constitutional tall stature	0.000	0.999	0.001
E34.2 Ectopic hormone secretion, not elsewhere classified	0.000	0.999	0.001
E34.1 Other hypersecretion of intestinal hormones	0.000	0.999	0.001
H02.4 Ptosis of eyelid	0.001	0.999	0.000
H57.0 Anomalies of pupillary function	0.001	0.999	0.000
I72 Other aneurysm	0.001	0.999	0.000
E40-E46 Malnutrition	0.000	0.999	0.001
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.000	0.999	0.001
E22.1 Hyperprolactinaemia	0.000	0.999	0.001
E29.1 Testicular hypofunction	0.000	0.999	0.001
I72.0 Aneurysm of carotid artery	0.001	0.999	0.000
V18.1 Passenger injured in nontraffic accident	0.000	0.999	0.001
E03 Other hypothyroidism	0.001	0.999	0.000
E15 Nondiabetic hypoglycaemic coma	0.000	0.999	0.001
D68.8 Other specified coagulation defects	0.000	0.999	0.001
E34.3 Short stature, not elsewhere classified	0.000	0.999	0.001
H57.1 Ocular pain	0.001	0.999	0.000
J34.2 Deviated nasal septum	0.001	0.999	0.000
M65.84 Other synovitis and tenosynovitis (Hand)	0.000	0.999	0.001
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.999	0.001
J92.9 Pleural plaque without asbestos	0.001	0.999	0.000
T17.9 Foreign body in respiratory tract, part unspecified	0.001	0.999	0.000
T17.8 Foreign body in other and multiple parts of respiratory tract	0.001	0.999	0.000
V18.5 Passenger injured in traffic accident	0.000	0.999	0.001
E16 Other disorders of pancreatic internal secretion	0.000	0.999	0.001
M10.99 Gout, unspecified (Site unspecified)	0.000	0.999	0.001
I78.0 Hereditary haemorrhagic telangiectasia	0.001	0.999	0.000
E03.8 Other specified hypothyroidism	0.001	0.999	0.000
E34.8 Other specified endocrine disorders	0.000	0.999	0.001
E34.0 Carcinoid syndrome	0.000	0.999	0.001
I71.0 Dissection of aorta [any part]	0.001	0.999	0.000
V18.9 Unspecified pedal cyclist injured in traffic accident	0.000	0.999	0.001
V18.4 Driver injured in traffic accident	0.000	0.999	0.001
E67 Other hyperalimentation	0.000	0.999	0.001
E68 Sequelae of hyperalimentation	0.000	0.999	0.001
H04.1 Other disorders of lachrymal gland	0.001	0.999	0.000
I72.1 Aneurysm of artery of upper extremity	0.001	0.999	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.001	0.999	0.001
I71.8 Aortic aneurysm of unspecified site, ruptured	0.001	0.999	0.000
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations